In 2016, the global market for electronic clinical outcome assessment (eCOA solutions) was valued at USD 616.9million. Market growth is being driven by the increasing adoption of eCOA solutions by medical researchers. According to the Journal of Clinical Studies, 7% of all clinical trials currently use eCOA solutions in 2015. This number is expected to rise by 20% by 2018.
U.S. eCOA Solutions Market Revenue by Delivery Mode, 2014 - 2025 (USD Million)
The healthcare industry is experiencing a boom in terms of revenue, which means that there is a growing demand for research to develop new drugs and treatments. Due to the increasing number of research studies, there is a growing need for centralized data collection systems. These factors will drive product demand during the forecast period.
Pharmaceutical manufacturers are increasingly faced with increasing costs to develop new drugs and have shifted their preference towards electronic data capture from paper-based methods. The data capturing through eCOA platforms improves the quality of information received, harmonizes data collection procedures and offers significant value for its users such as data analysis.
The benefits of electronic-based data capturing and analyzing services are comparable to paper-based records but with a higher patient compliance. They reduce the risk of data variation and the cost of site monitoring. These solutions provide streamlined information that improves data quality and allows for the collection of information in a structured manner. These benefits associated with eCOA will drive product demand in the future.
Sponsors need to integrate patient care into clinical research studies. This leads to a surge in adoption of eCOA platforms.
The associated benefits of using web-hosted eCOA services accounted for the highest revenue share in 2016. Web-based services offer key features such as remote access to patient health information, sharing information to limit misuse of data, or to address problems at critical points of study.
These services are also easy to access, but require an IT infrastructure that is more expensive for smaller companies. CRF Health, Kayentis and ERT Solutions are just a few of the companies that offer web-based solutions. These products are offered by a variety of service providers, which keeps the competition high.
The market will be affected by the introduction of cloud-based platforms. These platforms provide a single platform through which patients, researchers, and sponsors have access to all medical information. The cloud-based eCOA services are expected to grow in value over the forecast period. Cloud-based solutions offer many advantages, which is why the preference for web-based services has changed from cloud-based to web-hosted.
Cloud-based platforms allow users to keep track all information. They also minimize the risk of data theft and provide a secure platform for information sharing.
Contract Research Organizations (CROs), which held the largest revenue share in 2016, are expected to see significant growth due to the growing demand from major pharmaceutical companies. The growth of the CROs segment is expected to be positive if pharma companies reduce the cost of clinical development studies.
To improve patient engagement in research studies hospitals are using electronic data capturing services. eCOA digitally collects information from both patients & doctors. eCOA captures information on handheld devices such as smartphones & tablets, interactive voice response systems, browsers, and patients' Bring-Your-Own-Device (BYOD). It uses secure systems that comply with regulatory guidelines to capture clinical data.
Market revenue for eCOA solutions in the global market by region, 2016, (%)
Adoption of mHealth devices, as well as the introduction of advanced technologies to patient care such BYOD are key growth drivers for the implementation of eCOA solutions in hospitals.
To meet regulatory requirements, pharma & biotech companies as well as medical device manufacturers prefer outsourcing research studies. However, some major companies have their own research divisions. eClinical services are less popular than other end users.
In 2016, North America was the largest region market. The future will see new drug development activity driven by the presence of medical device manufacturers, hospitals, research centers and universities as well as improved healthcare institutions.
In 2016, the U.S. held the largest North American market share due to its higher adoption of healthcare analytics services. Various government and non-profit organizations have taken initiatives to increase eClinical platform adoption. The industry is also supported by the strict regulations governing product approval and the implementation of eCOAs by established players in order to reduce expenditure on medical data management.
Asia Pacific, an emerging economy, is seeing a rise in government funding for clinical research and drug discovery. This is expected to boost market growth. The eClinical Services market is expected to be accentuated by the rising demand for personal care products and related services due to increased government spending on healthcare.
The rising demand for eCOA solutions is expected to be influenced by the emergence in India and China of major pharma & Biotech companies.
Global eCOA markets are highly competitive. Paraxel International Corporation, Oracle Corporation, Medidata Solution, Inc., Merge Healthcare Inc., Merge Healthcare Incorporated, BioClinica, eClinical Solutions, CRF Health, ERT Clinical, and OmniComm Systems, Inc. are some of the major players in this market.
To increase profits, these companies implement strategies like acquisitions, partnership agreements and distribution channel enhancement. CRF Health and Vodafone announced a partnership agreement in February 2017 to improve the services provided to clinical trial investigators and patients. CRF will now be able to access Vodafone's Machine to Machine platform.
In February 2015, ERT Clinical entered into a definitive deal with PHT Corporation. This agreement saw ERT acquire PHT as part of a portfolio expansion. This agreement will also allow ERT to expand its geographic footprint. Similar strategic initiatives are expected to increase competition during the forecast period.
This report predicts revenue growth at the global, regional and country levels. It also analyzes the industry trends for each sub-segment from 2014 through 2025. Grand View Research has divided the global eCOA market based on delivery mode, end use, and location.
Delivery Mode Outlook (Revenue USD Million, 2014-2025)
Web-hosted
Licensees
Cloud-based
End-use Outlook (Revenue USD Million, 2014-2025)
Hospitals
CROs
Academic Institutes
Pharma & Biotech Companies
Manufacturers of Medical Devices
Regional Outlook (Revenue USD Million, 2014-2025)
North America
The U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
Saudi Arabia
b. Global market for electronic clinical outcome assessment systems was valued at USD 932.8 Million in 2019. It is projected to grow to USD 1,071.9 Million in 2020.
What is the market growth for electronic clinical outcome assessment systems?b. Global electronic clinical outcome assessment market will grow at a compound annual rate of 15.1% between 2019 and 2025, reaching USD 2,169.0 millions by 2025.
Which segment had the largest market share for electronic clinical outcome assessments solutions?b. With a 50.38% share in 2019, North America was the dominant market for electronic clinical outcome assessment systems. This can be attributed to the existence of medical device manufacturers, hospitals, universities and research centers that are technologically advanced, as well as improved healthcare facilities.
What are the major players in the electronic clinical outcome assessment market?b. b.
What are the driving factors for the electronic clinical outcome assessment market?b. b.
Up Market Research published a new report titled “Electronic Clinical Outcome Assessment Solutions Market research report which is segmented by Delivery Mode (Web-hosted, Cloud-based, Licensed Enterprise), by End Use (Hospitals, Biotech), By Players/Companies Oracle Corporation; Paraxel International Corporation; Medidata Solution, Inc, Inc; Merge Healthcare Incorporated; BioClinica; eClinical Solutions; CRF Health; ERT Clinical; and OmniComm Systems”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Electronic Clinical Outcome Assessment Solutions Market Research Report |
By Delivery Mode | Web-hosted, Cloud-based, Licensed Enterprise |
By End Use | Hospitals, Biotech |
By Companies | Oracle Corporation; Paraxel International Corporation; Medidata Solution, Inc, Inc; Merge Healthcare Incorporated; BioClinica; eClinical Solutions; CRF Health; ERT Clinical; and OmniComm Systems |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 219 |
Number of Tables & Figures | 154 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Delivery Mode (Web-hosted, Cloud-based, Licensed Enterprise), by End Use (Hospitals, Biotech).
Electronic Clinical Outcome Assessment Solutions Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Electronic Clinical Outcome Assessment Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Electronic Clinical Outcome Assessment Solutions Market Report:
Some other reports from this category!